Cargando…
Pharmaceutical regulation in Europe and its impact on corporate R&D
OBJECTIVES: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...
Autores principales: | Eger, Stephan, Mahlich, Jörg C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502069/ https://www.ncbi.nlm.nih.gov/pubmed/26208924 http://dx.doi.org/10.1186/s13561-014-0023-5 |
Ejemplares similares
-
The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?
por: Mahlich, Jörg, et al.
Publicado: (2023) -
Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis
por: Mahlich, Jörg, et al.
Publicado: (2021) -
Is there a moderate range of impact of financialization on corporate R&D?
por: Li, Zhenghui, et al.
Publicado: (2021) -
Transnational corporations in the pharmaceutical industry of developing countries.
Publicado: (1984) -
Corporate social responsibility of pharmaceutical industry in Korea
por: Bae, Green, et al.
Publicado: (2022)